Identification of novel genes by targeted exome sequencing in Retinoblastoma

References

• Noone A, Howlader N, Krapcho M. SEER cancer statistics review, 1975-2015. Bethesda, MD: National Cancer Institute; 2018.
   Google Scholar
• Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Nat Acad Sci. 1971;68(4):820–23. doi:10.1073/pnas.68.4.820.
   PubMed Web of Science ®Google Scholar
• Jain M, Rojanaporn D, Chawla B, Sundar G, Gopal L, Khetan V. Retinoblastoma in Asia. Eye. 2019;33(1):87–96. doi:10.1038/s41433-018-0244-7.
   PubMed Web of Science ®Google Scholar
• Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012;379(9824):1436–46. doi:10.1016/S0140-6736(11)61137-9.
   PubMed Web of Science ®Google Scholar
• Pentimalli F, Indovina P, Giordano A. Retinoblastoma beyond RB1: recent advances in genetic biomarkers. Expert Rev Ophthalmol. 2010;5(6):717–21. doi:10.1586/eop.10.75.
   Google Scholar
• Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC, Squire JA. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008;17(10):1363–72. doi:10.1093/hmg/ddn024.
   PubMed Web of Science ®Google Scholar
• Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2001;129(1):57–63. doi:10.1016/s0165-4608(01)00427-7.
   PubMedGoogle Scholar
• Thériault BL, Dimaras H, Gallie BL, Corson TW. The genomic landscape of retinoblastoma: a review. Clin Exp Ophthalmol. 2014;42(1):33–52. doi:10.1111/ceo.12132.
   PubMed Web of Science ®Google Scholar
• Sampieri K, Amenduni M, Papa FT, Katzaki E, Mencarelli MA, Marozza A, Epistolato MC, Toti P, Lazzi S, Bruttini M. Array comparative genomic hybridization in retinoma and retinoblastoma tissues. Cancer Sci. 2009;100(3):465–71. doi:10.1111/j.1349-7006.2008.01070.x.
   PubMed Web of Science ®Google Scholar
• Levin JZ, Berger MF, Adiconis X, Rogov P, Melnikov A, Fennell T, Nusbaum C, Garraway LA, Gnirke A. Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome Biol. 2009;10(10):1–8. doi:10.1186/gb-2009-10-10-r115.
   Web of Science ®Google Scholar
• Devarajan B, Prakash L, Kannan TR, Abraham AA, Kim U, Muthukkaruppan V, Vanniarajan A. Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma. BMC Cancer. 2015;15(1):320. doi:10.1186/s12885-015-1340-8.
   PubMed Web of Science ®Google Scholar
• Thirumalairaj K, Abraham A, Devarajan B, Gaikwad N, Kim U, Muthukkaruppan V, Vanniarajan A. A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients. J Hum Genet. 2015;60(9):547–52. doi:10.1038/jhg.2015.62.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Russell DW. Isolation of high-molecular-weight DNA from mammalian cells using formamide. Cold Spring Harb Protoc. 2006;2006(1):pdb–prot3225.
   Google Scholar
• Zhu K, Day T, Warshaviak D, Murrett C, Friesner R, Pearlman D. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction. Proteins Struct Funct Bioinf. 2014;82(8):1646–55. doi:10.1002/prot.24551.
   PubMed Web of Science ®Google Scholar
• Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang change Y. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2015;12(1):7–8. doi:10.1038/nmeth.3213.
   PubMed Web of Science ®Google Scholar
• Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–76. doi:10.1038/nmeth0810-575.
   PubMed Web of Science ®Google Scholar
• Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073. doi:10.1038/nprot.2009.86.
   PubMed Web of Science ®Google Scholar
• Sunyaev S, et al. Prediction of deleterious human alleles. Hum Mol Genet. 2001;10(6):591–97. doi:10.1093/hmg/10.6.591.
   PubMed Web of Science ®Google Scholar
• Giacinti C, Giordano A. RB and cell cycle progression. Oncogene. 2006;25(38):5220–27. doi:10.1038/sj.onc.1209615.
   PubMed Web of Science ®Google Scholar
• McEvoy J, Nagahawatte P, Finkelstein D, Richards-Yutz J, Valentine M, Ma J, Mullighan C, Song G, Chen X, Wilson M. RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget. 2014;5(2):438. doi:10.18632/oncotarget.1686.
   PubMedGoogle Scholar
• Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet. 2003;72(2):253–69. doi:10.1086/345651.
   PubMed Web of Science ®Google Scholar
• Mandel CR, Bai Y, Tong L. Protein factors in pre-mRNA 3′-end processing. Cell Mol Life Sci. 2008;65(7–8):1099–122. doi:10.1007/s00018-007-7474-3.
   PubMed Web of Science ®Google Scholar
• Curinha A, Oliveira Braz S, Pereira-Castro I, Cruz A, Moreira A. Implications of polyadenylation in health and disease. Nucleus. 2014;5(6):508–19. doi:10.4161/nucl.36360.
   PubMed Web of Science ®Google Scholar
• Mayr C, Bartel DP. Widespread shortening of 3′ UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell. 2009;138(4):673–84. doi:10.1016/j.cell.2009.06.016.
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRnas. Ann Rev Biochem. 2010;79:351–79.
   PubMed Web of Science ®Google Scholar
• Chai Y-S, Yuan Z-Y, Lei F, Wang Y-G, Hu J, Du F, Lu X, Jiang J-F, Xing D-M, Du L-J. Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of berberine against cerebral ischemia. PLoS One. 2014;9(3):e90850. doi:10.1371/journal.pone.0090850.
   PubMed Web of Science ®Google Scholar
• Leander C, Fu LC, Peña A, Howard SC, Rodriguez-Galindo C, Wilimas JA, Ribeiro RC, Haik B. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer. 2007;49(6):817–19. doi:10.1002/pbc.21052.
   PubMed Web of Science ®Google Scholar
• Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323(6089):643–46. doi:10.1038/323643a0.
   PubMed Web of Science ®Google Scholar
• Rushlow DE, Mol BM, Kennett JY, Yee S, Pajovic S, Thériault BL, Prigoda-Lee NL, Spencer C, Dimaras H, Corson TW. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 2013;14(4):327–34. doi:10.1016/S1470-2045(13)70045-7.
   PubMed Web of Science ®Google Scholar
• Stenfelt S, Blixt MKE, All‐ericsson C, Hallböök F, Boije H. Heterogeneity in retinoblastoma: a tale of molecules and models. Clin Transl Med. 2017;6(1):1–14. doi:10.1186/s40169-017-0173-2.
   PubMedGoogle Scholar
• Arora R, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46(4):264. doi:10.4103/0019-509X.55546.
   PubMedGoogle Scholar
• Gallie B Keynote lecture. World internet survey of classification of retinoblastoma. In XI International Congress of Ocular Oncology. Hyderabad, India; 2004.
   Google Scholar
• Devarajan B, Prakash L, Kannan TR, Abraham AA, Kim U, Muthukkaruppan V, Vanniarajan A. Targeted next generation sequencing of RB1 gene for the molecular diagnosis of Retinoblastoma. BMC Cancer. 2015;15(1):1–10.
   PubMedGoogle Scholar
• Tomar S, Sethi R, Sundar G, Quah TC, Quah BL, Lai PS. Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling. PLoS One. 2017;12(6):e0178776. doi:10.1371/journal.pone.0178776.
   PubMed Web of Science ®Google Scholar
• Domenico M, Cosimo L, Giovanni G. Retinoblastoma as an epigenetic disease: a proposal. J Cancer Ther. 2011.
   Google Scholar
• Price EA, Price K, Kolkiewicz K, Hack S, Reddy MA, Hungerford JL, Kingston JE, Onadim Z. Spectrum of RB1 mutations identified in 403 retinoblastoma patients. J Med Genet. 2014;51(3):208–14. doi:10.1136/jmedgenet-2013-101821.
   PubMed Web of Science ®Google Scholar
• Jiang D, LaGory EL, Brož DK, Bieging KT, Brady CA, Link N, Abrams JM, Giaccia AJ, Attardi LD. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function. Cell Rep. 2015;10(7):1096–109.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Sakuma J, Takeuchi I, Yasukochi Y, Kato K, Oguri M, Fujimaki T, Horibe H, Muramatsu M, Sawabe M. Identification of C21orf59 and ATG2A as novel determinants of renal function-related traits in Japanese by exome-wide association studies. Oncotarget. 2017;8(28):45259. doi:10.18632/oncotarget.16696.
   PubMedGoogle Scholar
• Hickman ES, Moroni MC, Helin K. The role of p53 and pRB in apoptosis and cancer. Curr Opin Gene Develop. 2002;12(1):60–66.
   PubMed Web of Science ®Google Scholar
• Chen L, Tweddle DA. P53, SKP2, and DKK3 as MYCN target genes and their potential therapeutic significance. Front Oncol. 2012;2:173. doi:10.3389/fonc.2012.00173.
   PubMedGoogle Scholar
• Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature. 2009;459(7245):356–63. doi:10.1038/nature08144.
   PubMed Web of Science ®Google Scholar
• Tuteja N. Signaling through G protein coupled receptors. Plant Signaling Behav. 2009;4(10):942–47. doi:10.4161/psb.4.10.9530.
   PubMedGoogle Scholar
• Moore M, Gammon L, Dreger S, Koh J, Garbe JC, Stampfer MR, Philpott M, Jones L, Bishop CL. Ribosomal stress-induced senescence as a novel pro-senescence strategy for p16 positive basal-like breast cancer. bioRxiv. 2018:469445.
   Google Scholar
• Labrecque MP, Takhar MK, Nason R, Santacruz S, Tam KJ, Massah S, Haegert A, Bell RH, Altamirano-Dimas M, Collins CC. The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells. Oncotarget. 2016;7(17):24284. doi:10.18632/oncotarget.8301.
   PubMedGoogle Scholar
• Singh A, Nunes JJ, Ateeq B. Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases. Eur J Pharmacol. 2015;763:178–83. doi:10.1016/j.ejphar.2015.05.011.
   PubMed Web of Science ®Google Scholar
• Jan LY, Jan YN. Voltage‐gated potassium channels and the diversity of electrical signalling. J Physiol. 2012;590(11):2591–99. doi:10.1113/jphysiol.2011.224212.
   PubMed Web of Science ®Google Scholar
• Shah NH, Aizenman E. Voltage-Gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration. Transl Stroke Res. 2014;5(1):38–58. doi:10.1007/s12975-013-0297-7.
   PubMed Web of Science ®Google Scholar
• Del Toro N, Lessard F, Tardif S, Bouchard J, Bourdeau V, Ferbeyre G, Brakier-Gingras L. The retinoblastoma tumor suppressor limits ribosomal readthrough during oncogene induced senescence. bioRxiv. 2019:788380.
   Google Scholar
• Sarour SM, Zayed AM, Ibrahim MO, Albadry DE, Hassan MM, Yousif OE, Salih MA. New mutation found within OTOR gene involved in deafness in two Sudanese families from Al-Jazirah state-Sudan: using Next Generation Sequencing (NGS). Bio-Genet J. 2014;2(6):46–50.
   Google Scholar
• Zhu H, Chen L, Zhou W, Huang Z, Hu J, Dai S, Wang X, Huang X, He C. Over-Expression of the ATP5J gene correlates with cell migration and 5-fluorouracil sensitivity in colorectal cancer. PLoS One. 2013;8(10):e76846. doi:10.1371/journal.pone.0076846.
   PubMed Web of Science ®Google Scholar
• Goding JW, Grobben B, Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim Biophys Acta. 2003;1638(1):1–19. doi:10.1016/s0925-4439(03)00058-9.
   PubMed Web of Science ®Google Scholar
• Han F, Liu W, Jiang X, Shi X, Yin L, Ao L, Cui Z, Li Y, Huang C, Cao J. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer. Oncogene. 2015;34(33):4391–402. doi:10.1038/onc.2014.370.
   PubMed Web of Science ®Google Scholar
• Feng C-W-A, Spiller C, Merriner DJ, O’Bryan MK, Bowles J, Koopman P. SOX30 is required for male fertility in mice. Sci Rep. 2017;7(1):1–12. doi:10.1038/s41598-017-17854-5.
   PubMedGoogle Scholar
• Mansouri K, Mostafie A, Rezazadeh D, Shahlaei M, Modarressi MH. New function of TSGA10 gene in angiogenesis and tumor metastasis: a response to a challengeable paradox. Hum Mol Genet. 2016;25(2):233–44. doi:10.1093/hmg/ddv461.
   PubMed Web of Science ®Google Scholar
• Jen J, Wang Y-C. Zinc finger proteins in cancer progression. J Biomed Sci. 2016;23(1):53. doi:10.1186/s12929-016-0269-9.
   PubMed Web of Science ®Google Scholar
• Grudzien-Nogalska E, Jiao X, Song M-G, Hart RP, Kiledjian M. Nudt3 is an mRNA decapping enzyme that modulates cell migration. RNA. 2016;22(5):773–81. doi:10.1261/rna.055699.115.
   PubMed Web of Science ®Google Scholar
• Yendamuri S, Trapasso F, Calin GA. Arlts1–a novel tumor suppressor gene. Cancer Lett. 2008;264(1):11–20. doi:10.1016/j.canlet.2008.02.021.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhao C-Y, Cheng L-C, Xu B, Lv H-Y. ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis. Hered Cancer Clin Pract. 2017;15(1):8. doi:10.1186/s13053-017-0068-7.
   PubMedGoogle Scholar
• Fu S, Guo Y, Chen H, Xu Z-M, Qiu G-B, Zhong M, Sun K-L, Fu W-N. MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis. PLoS One. 2011;6(10):e25648. doi:10.1371/journal.pone.0025648.
   PubMed Web of Science ®Google Scholar
• Fu S, Fu Y, Chen F, Hu Y, Quan B, Zhang J. Overexpression of MYCT1 inhibits proliferation and induces apoptosis in human acute myeloid leukemia HL-60 and KG-1a cells in vitro and in vivo. Front Pharmacol. 2018;9:1045.
   PubMed Web of Science ®Google Scholar
• Woo C-W, Tan F, Cassano H, Lee J, Lee KC, Thiele CJ. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma. Pediatr Blood Cancer. 2008;50(2):208–12. doi:10.1002/pbc.21195.
   PubMed Web of Science ®Google Scholar
• Barr FG, Duan F, Smith LM, Gustafson D, Pitts M, Hammond S, Gastier‐Foster JM. Genomic and clinical analyses of 2p24 and 12q13‐q14 amplification in alveolar rhabdomyosarcoma: a report from the Children’s Oncology Group. Genes Chromosomes Cancer. 2009;48(8):661–72.
   PubMed Web of Science ®Google Scholar
• Moreau LA, McGrady P, London WB, Shimada H, Cohn SL, Maris JM, Diller L, Look AT, George RE. Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? a Children’s Oncology Group Study. Clin Cancer Res. 2006;12(19):5693–97. doi:10.1158/1078-0432.CCR-06-1500.
   PubMed Web of Science ®Google Scholar
• Kooi IE, Mol BM, Moll AC, van der Valk P, de Jong MC, de Graaf P, van Mil SE, Schouten-van Meeteren AYN, Meijers-Heijboer H, Kaspers GL. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. EBioMedicine. 2015;2(7):660–70. doi:10.1016/j.ebiom.2015.06.022.
   PubMed Web of Science ®Google Scholar
• Kumar SB, Chawla B, Bisht S, Yadav RK, Dada R, et al. Tobacco use increases oxidative DNA damage in sperm - possible etiology of childhood cancer. Asian Pac J Cancer Prev. 2015;16(16):6967–72. doi:10.7314/APJCP.2015.16.16.6967.
   PubMedGoogle Scholar
• Bisht S, Chawla B, Dada R. 8-Hydroxy-2’-Deoxyguanosine in sperm DNA and increased risk of nonfamilial sporadic heritable retinoblastoma in the child. J Pediatr Genet. 2020;9(02):145–48. doi:10.1055/s-0039-1700974.
   PubMedGoogle Scholar
• Mastrangelo D, Loré C, Grasso G. Retinoblastoma as an epigenetic disease: a proposal. J Cancer Ther. 2011;2(03):362. doi:10.4236/jct.2011.23049.
   Google Scholar
• Bisht S, Chawla B, Dada R. Oxidative stress and polymorphism in MTHFR SNPs (677 and 1298) in paternal sperm DNA is associated with an increased risk of retinoblastoma in their children: a case–control study. J Pediatr Genet. 2018;7(03):103–13. doi:10.1055/s-0038-1667037.
   PubMedGoogle Scholar
• Tunc O, Tremellen K. Oxidative DNA damage impairs global sperm DNA methylation in infertile men. J Assist Reprod Genet. 2009;26(9):537–44. doi:10.1007/s10815-009-9346-2.
   PubMed Web of Science ®Google Scholar
• Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Ann Rev Pharmacol Toxicol. 2005;45(1):629–56. doi:10.1146/annurev.pharmtox.45.120403.095832.
   PubMedGoogle Scholar
• Kooi I. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci Rep. 2016;6(1):25264. doi:10.1038/srep25264.
   PubMed Web of Science ®Google Scholar